The strategies for treating PRMS include:
- Modifying the disease course
- The interferon beta medications (Avonex®, Betaseron®, and Rebif®) and Tysabri® (natalizumab) are approved by the FDA for use in relapsing forms of MS, which include people with progressive-relapsing MS who continue to have relapses. If the person’s physician feels that none of these first-line medications is doing an adequate job of controlling disease activity, he or she will likely recommend changing to Tysabri (natalizumab) or Novantrone® (mitoxantrone).
- Managing symptoms
- Regardless of the course of MS a person is experiencing, proactive symptom management is essential to maintaining comfort and productivity, and enhancing quality of life.
- Enhancing mobility and promoting safety and independence
- Rehabilitation specialists have an important role, from the time of diagnosis onward, in helping people function optimally in spite of their MS
- Promoting overall health and wellness
- Health and wellness can be achieved even in the presence of a chronic illness or disability.
- Promoting emotional well-being and quality of life